-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
NovaBay Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- NovaBay Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending December 31, 2023 was $12K, a 62.5% decline year-over-year.
- NovaBay Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the twelve months ending December 31, 2023 was $51K, a 57.5% decline year-over-year.
- NovaBay Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2023 was $51K, a 57.5% decline from 2022.
- NovaBay Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $120K, a 103% increase from 2021.
- NovaBay Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $59K, a 15.7% increase from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)